efficacy of hepatitis b virus surface antigen vaccine as a therapeutic tool, in inactive hepatitis b virus carriers

نویسندگان

ghodratollah montazeri

zahra farzadi

atossa fazllolahi

shifteh abedian

چکیده

background: available drugs are not able to eradicate intracellular viral dna in patients with hepatitis b virus (hbv) infections. hbsag vaccine could induce immunity and subsequently eradicate hepatitis b virus in proportions of these patients. our aim was to evaluate the efficacy of hbsag as a mode of therapy in inactive carriers. materials and methods: forty two consecutive patients of inactive carriers were enrolled. all patients underwent liver biopsies. the modified ishak score of all cases were less than 4. twenty microgram of recombinant hbsag vaccine injected intradermally 3 times (at 0, one and 6 months). biochemical and serological variables evaluated initially and 6 months after the last injection. results: the mean age was 39.6 â± 11.12. male/female ratio was (67.4%). two out of 42 cases lost their hbsag (4.74%). the difference was significant comparing to one percent annual spontaneous hbsag loss (p=0.014). in addition serum albumin level was significantly increased after vaccination (p=0.009). rest of the biochemical and serological variables had no significant changes comparing pre and post vaccination. conclusions:â  intradermal injection of hbv surface antigen vaccine could induce significant hbsag loss. this mode of therapy is cheap, physiologic and without complication. however, the results of this study should be confirmed in further large controlled trial.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Incidence of Hepatitis B virus Surface Antigen (HBsAg) Mutations in Naïve Treated of Chronic Carriers from Tehran Metropolis, Iran

Abstract Background: Naturally occurred hepatitis B virus (HBV) with surface mutations in a variety of chronic hepatitis B (CHB) patients who have received no vaccine or HBIG bearing substitutions in surface protein, have been reported. Objectives: Current knowledge concerning the prevalence of these naturally occurring surface antigen mutations among Iranian carriers is limited. Patients and M...

متن کامل

Hepatitis B Virus Surface Antigen Variants Clustered Within Immune Epitopes in Chronic Hepatitis B Carriers from Hormozgan Province, South of Iran

Objective(s) The aim of this study was to characterize the hepatitis B virus surface protein genotypes and sequence variations among hepatitis B virus surface antigen (HBsAg) positive chronic patients in Hormozgan province, south of Iran. Materials and Methods A total of 8 patients enrolled in this study. The surface gene was amplified and directly sequenced. Genotypes and nucleotide/amino a...

متن کامل

Inactive Carriers of Hepatitis B Virus: A Never Ending Story

t o b The so-called inactive carriers are regularly revisited in hepatologist’s literature, but many pending issues are yet unsolved. Magalhães et al looked back in to a cohort of patients carefully followed with serial assessment of some blood parameters, trying to indirectly validate their own strategy of monitoring. Patients infected with hepatitis B virus (HBV) present several patterns of s...

متن کامل

Efficacy of Four Disinfectants Against Hepatitis B Virus

Background and Aim: Hepatitis B virus (HBV) is an important infectious agent in denti-stry necessitating the use of disinfectants to prevent its transmission. This study compared the efficacy of 2/100 sodium hypochlorite disinfectants prepared from 5% solution manufactured by four different manufacturers namely Ashimashi, Paknaz, Vitex and Active for disinfection of surfaces infected with HBV. ...

متن کامل

Reactivation of Hepatitis B Virus: Inactive Carriers and Occult Infection

In recent years the group of inactive carriers and that of occult hepatitis B virus infection could become a main concern due to their epidemiological and clinical significance. At present, our top priority consists of identifying, prophylaxis and monitoring of these patients undergoing immunosuppressive treatment. This report describes hepatitis B virus reactivation in the two patients in diff...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
گوارش

جلد ۱۰، شماره ۴، صفحات ۲۲۷-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023